![](/img/cover-not-exists.png)
Out-of-pocket costs for PARP inhibitor treatment: Are ovarian cancer patients at risk for financial toxicity?
Harrison, R.F., Fu, S., Sun, C.C., Zhao, H., Lu, K.H., Giordano, S.H., Meyer, L.Volume:
159
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2020.06.041
Date:
October, 2020
File:
PDF, 69 KB
2020